Spain· ES:114914001
VIMIZIM 1MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing elosulfasa alfa, registered in Spain by Biomarin International Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- elosulfasa alfa
- Manufacturer
- Biomarin International Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elosulfasa alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanエロスルファーゼ アルファ（遺伝子組換え）ＢｉｏＭａｒｉｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｊａｐａｎ
- United KingdomVimizim 5mg/5ml concentrate for solution for infusion vialsBioMarin (U.K.) Ltd
- NorwayVimizimBioMarin International Limited
- CzechiaVIMIZIMBioMarin International Limited, Dublin
- FinlandVimizimBiomarin International Limited
- FranceVIMIZIM 1 mg/ml, solution à diluer pour perfusionBIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- IrelandVimizim 1 mg/ml concentrate for solution for infusionBiomarin International Limited
- IcelandVimizimBioMarin International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vimizim
- Liechtenstein · Vimizim
- Norway · Vimizim
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0b063489-f0ef-4d83-891c-b59e1e79c504 GET /v1/drugs/0b063489-f0ef-4d83-891c-b59e1e79c504?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1427065200000}",
"nregistro": "114914001",
"substance": "elosulfasa alfa"
}See everything about elosulfasa alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.